Arvinas, Inc.
ARVN- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001655759
No open-market purchases or sales by Arvinas, Inc. insiders were filed in the last 90 days; 201 institutions reported holding it in 13F filings for Q2 2026, worth $468.7M in total; no superinvestor holds it.
13F holders, Q1 2025
Institutional positions in Arvinas, Inc. as of Mar 31, 2025. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 216
- +20 vs. Q4 2024
- Shares held
- 65.1M
- −9.85M (−13.1%) vs. Q4 2024
- Total value
- $456.7M
- −$983.2M (−68.3%) vs. Q4 2024
- New holders
- 56
- 72 more added
- Sold out
- 36
- 60 more reduced
3 institutions that held it in Q4 2024 haven't filed for Q1 2025 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.
Compare with Q4 2024: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting ARVN on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 201 | $468.7M |
| Q1 2026 | 207 | $572.6M |
| Q4 2025 | 206 | $662.9M |
| Q3 2025 | 211 | $570.7M |
| Q2 2025 | 215 | $513.8M |
| Q1 2025 | 216 | $456.7M |
| Q4 2024 | 199 | $1.47B |
| Q3 2024 | 206 | $1.78B |
| Q2 2024 | 207 | $1.89B |
| Q1 2024 | 223 | $2.84B |
| Q4 2023 | 213 | $2.67B |
| Q3 2023 | 155 | $959.0M |
| Q2 2023 | 156 | $1.16B |
| Q1 2023 | 171 | $1.34B |
| Q4 2022 | 162 | $1.71B |
| Q3 2022 | 174 | $2.22B |
| Q2 2022 | 172 | $2.08B |
| Q1 2022 | 179 | $3.16B |
| Q4 2021 | 199 | $3.69B |
| Q3 2021 | 205 | $3.64B |
| Q2 2021 | 181 | $3.52B |
| Q1 2021 | 181 | $2.88B |
Institutions, Q1 2025
Shares, value and share of portfolio for each institution holding Arvinas, Inc.; share changes are against Q4 2024.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Sterling Capital Management LLC | 66 | $463 | 0.00% | 00.0% | Unchanged |
| First Horizon Advisors, Inc. | 65 | $456 | 0.00% | −367−85.0% | Reduced |
| Comerica Bank | 62 | $435 | 0.00% | 00.0% | Unchanged |
| Stephens Consulting, LLC | 45 | $316 | 0.00% | +45 | New |
| Farther Finance Advisors, LLC | 40 | $281 | 0.00% | −49−55.1% | Reduced |
| Parkside Financial Bank & Trust | 30 | $211 | 0.00% | +30 | New |
| Bell Investment Advisors, Inc | 26 | $183 | 0.00% | 00.0% | Unchanged |
| True Wealth Design, LLC | 23 | $162 | 0.00% | +23 | New |
| EverSource Wealth Advisors, LLC | 19 | $133 | 0.00% | +6+46.2% | Added |
| IFP Advisors, Inc | 0 | $63 | 0.00% | 0 | Unchanged |
| Smartleaf Asset Management LLC | 8 | $60 | 0.00% | −205−96.2% | Reduced |
| Carolinas Wealth Consulting LLC | 3 | $21 | 0.00% | 00.0% | Unchanged |
| Leonteq Securities AG | 2 | $14 | 0.00% | 00.0% | Unchanged |
| Capital Advisors, Ltd. LLC | 13 | $0 | 0.00% | −15−53.6% | Reduced |
| Avion Wealth | 33 | $0 | 0.00% | +33 | New |
| DekaBank Deutsche Girozentrale | 42,000 | – | – | 00.0% | Unchanged |
| EcoR1 Capital, LLC | 0 | $0 | 0.00% | −6,726,491−100.0% | Sold out |
| Bellevue Group AG | 0 | $0 | 0.00% | −2,389,600−100.0% | Sold out |
| ArrowMark Colorado Holdings LLC | 0 | $0 | 0.00% | −1,776,555−100.0% | Sold out |
| Boxer Capital Management, LLC | 0 | $0 | 0.00% | −1,058,614−100.0% | Sold out |
| Perceptive Advisors LLC | 0 | $0 | 0.00% | −740,749−100.0% | Sold out |
| Logos Global Management LP | 0 | $0 | 0.00% | −700,000−100.0% | Sold out |
| Affinity Asset Advisors, LLC | 0 | $0 | 0.00% | −630,000−100.0% | Sold out |
| Candriam Luxembourg S.C.A. | 0 | $0 | 0.00% | −503,936−100.0% | Sold out |
| Wasatch Advisors Inc | 0 | $0 | 0.00% | −436,241−100.0% | Sold out |
| Ra Capital Management, L.P. | 0 | $0 | 0.00% | −421,348−100.0% | Sold out |
| Baker Bros. Advisors LP | 0 | $0 | 0.00% | −405,576−100.0% | Sold out |
| Panagora Asset Management Inc | 0 | $0 | 0.00% | −297,186−100.0% | Sold out |
| Frazier Life Sciences Management, L.P. | 0 | $0 | 0.00% | −285,331−100.0% | Sold out |
| BIT Capital GmbH | 0 | $0 | 0.00% | −263,527−100.0% | Sold out |
| American Century Companies Inc | 0 | $0 | 0.00% | −252,685−100.0% | Sold out |
| Neuberger Berman Group LLC | 0 | $0 | 0.00% | −164,392−100.0% | Sold out |
| Twinbeech Capital LP | 0 | $0 | 0.00% | −164,112−100.0% | Sold out |
| Ameriprise Financial Inc | 0 | $0 | 0.00% | −116,513−100.0% | Sold out |
| Parkman Healthcare Partners LLC | 0 | $0 | 0.00% | −106,871−100.0% | Sold out |
| Patient Square Capital LP | 0 | $0 | 0.00% | −86,627−100.0% | Sold out |
| Standard Life Aberdeen plc | 0 | $0 | 0.00% | −78,585−100.0% | Sold out |
| Bank of Montreal | 0 | $0 | 0.00% | −39,407−100.0% | Sold out |
| Voloridge Investment Management, LLC | 0 | $0 | 0.00% | −39,063−100.0% | Sold out |
| SG Americas Securities, LLC | 0 | $0 | 0.00% | −32,424−100.0% | Sold out |
| M&T Bank Corp | 0 | $0 | 0.00% | −31,673−100.0% | Sold out |
| Brevan Howard Capital Management LP | 0 | $0 | 0.00% | −19,249−100.0% | Sold out |
| DnB Asset Management AS | 0 | $0 | 0.00% | −10,234−100.0% | Sold out |
| Skandinaviska Enskilda Banken AB (publ) | 0 | $0 | 0.00% | −9,806−100.0% | Sold out |
| Virtus ETF Advisers LLC | 0 | $0 | 0.00% | −3,601−100.0% | Sold out |
| Coppell Advisory Solutions LLC | 0 | $0 | 0.00% | −1,133−100.0% | Sold out |
| Skopos Labs, Inc. | 0 | $0 | 0.00% | −797−100.0% | Sold out |
| Venturi Wealth Management, LLC | 0 | $0 | 0.00% | −242−100.0% | Sold out |
| Nelson, Van Denburg & Campbell Wealth Management Group, LLC | 0 | $0 | 0.00% | −232−100.0% | Sold out |
| Aster Capital Management (DIFC) Ltd | 0 | $0 | 0.00% | −57−100.0% | Sold out |
| SRS Capital Advisors, Inc. | 0 | $0 | 0.00% | −34−100.0% | Sold out |
| Cornerstone Planning Group LLC | 0 | $0 | 0.00% | −17−100.0% | Sold out |
| Nextech Invest AG | – | – | – | – | Not filed |
| Nuveen Asset Management, LLC | – | – | – | – | Not filed |
| Global Retirement Partners, LLC | – | – | – | – | Not filed |